Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.
about
Promising Therapy Candidates for Liver FibrosisTargeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon GammaA Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.New therapies for hepatic fibrosis.New Developments on the Treatment of Liver Fibrosis.Hepatic stellate cells as key target in liver fibrosis.Ameliorative Effects of Nilotinib on CCl4 Induced Liver Fibrosis Via Attenuation of RAGE/HMGB1 Gene Expression and Oxidative Stress in Rat.
P2860
Q26766727-4DA2C454-8CBC-49F6-945A-4712E10A7B0FQ26779055-9B80427E-3CC4-4EC5-AF93-311498E364CEQ36005098-D1769BF4-B864-4660-806A-7496B5D9DED5Q38553309-6ECFA0BA-903A-48A7-9C43-BB7662582458Q38873303-82432952-859B-4254-BF29-1504155357A0Q40200602-BC80F94C-74AB-4C30-9E7C-6D55073380CDQ42223709-E3D9B3F9-4620-49D7-BAB0-98214E175A26
P2860
Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Early to Phase II drugs curren ...... e treatment of liver fibrosis.
@en
type
label
Early to Phase II drugs curren ...... e treatment of liver fibrosis.
@en
prefLabel
Early to Phase II drugs curren ...... e treatment of liver fibrosis.
@en
P2093
P2860
P1476
Early to Phase II drugs curren ...... e treatment of liver fibrosis.
@en
P2093
Matthias Ocker
Peter Hauff
Ulrich Gottwald
P2860
P304
P356
10.1517/13543784.2015.997874
P407
P577
2014-12-30T00:00:00Z